Literature DB >> 404101

Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease.

C S Teng, B R Smith, B Clayton, D C Evered, F Clark, R Hall.   

Abstract

Thyroid-stimulating immunoglobulins (TSI) have been detected by receptor assay in the sera of 43% of patients with ophthalmic Graves' disease. Comparison of the receptor assay studies with thyroid function tests indicated that in several patients the antibodies detected by receptor assay were biologically inactive. In other patients, thyroid function appeared to be under TSI control with hyperthyroidism prevented by autoimmune destruction of the thyroid.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 404101     DOI： 10.1111/j.1365-2265.1977.tb03316.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


  21 in total

1.  TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.

Authors:  G Schernthaner; H Ludwig; H Schleusener; R Finke; P Kotulla; W R Mayr
Journal:  Experientia       Date:  1979-10-15

Review 2.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

3.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

4.  Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

Authors:  J Ginsberg; C von Westarp
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

5.  In vitro production of thyroid-binding antibodies by peripheral blood lymphocytes from patients with Graves' disease: nonspecific responses associated with culture supernatant proteins.

Authors:  J R Wall; C R Strakosch; A Trewin; D M Joyner
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

6.  Progress in endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1979-04-14

Review 7.  Risk factors for development or deterioration of Graves' ophthalmopathy.

Authors:  Marius N Stan; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

8.  A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.

Authors:  P Kendall-Taylor; S Atkinson; M Holcombe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

9.  Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.

Authors:  J R Baker; Y G Lukes; K D Burman
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy.

Authors:  J R Wall; B A Walters; C Grant
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.